These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25846673)

  • 1. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Zimarino M; Ricci F; Romanello M; Di Nicola M; Corazzini A; De Caterina R
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):3-12. PubMed ID: 25846673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
    Bang VV; Levy MS
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):13-4. PubMed ID: 27410951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivessel Coronary Revascularization Strategies in Patients with Chronic Kidney Disease: A Meta-Analysis.
    Wu P; Luo F; Fang Z
    Cardiorenal Med; 2019; 9(3):145-159. PubMed ID: 30844786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    Shah R; Berzingi C; Mumtaz M; Jasper JB; Goswami R; Morsy MS; Ramanathan KB; Rao SV
    Am J Cardiol; 2016 Nov; 118(10):1466-1472. PubMed ID: 27642115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
    El-Hayek GE; Gershlick AH; Hong MK; Casso Dominguez A; Banning A; Afshar AE; Herzog E; Tamis-Holland JE
    Am J Cardiol; 2015 Jun; 115(11):1481-6. PubMed ID: 25840579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and Propensity-Matched Studies.
    Ahmed A; Varghese KS; Fusco PJ; Mathew DM; Mathew SM; Ahmed S; Rogando DO; Salazar SA; Pandey R; Awad AK; Levy KH; Hernandez M; Calixte R
    Innovations (Phila); 2023; 18(1):29-40. PubMed ID: 36628960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.